Clinical Trial Update: S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity [Phase 3]

View source ↗

Summary

Phase 3 dual observational and randomized cohort study (S1501) evaluating patients with metastatic HER2-positive breast cancer at risk of cardiac toxicity; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Cardiotoxicity, HER2/Neu Positive | Phase 3 | Status: RECRUITING